Sarepta Therapeutics Inc (SRPT)

Debt-to-assets ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Long-term debt	US$ in thousands	1,133,660	1,132,520	1,236,760	1,235,520	1,234,280	1,544,290	1,542,770	1,100,870	1,098,850	1,096,880	1,094,910	1,092,980	1,091,110	992,493	700,470	694,156	687,953	681,900	436,421	431,040
Total assets	US$ in thousands	3,224,380	3,264,580	3,109,710	3,125,890	3,059,790	3,128,370	3,156,150	2,996,850	3,056,150	3,147,970	2,662,220	2,759,070	2,765,230	2,984,720	2,780,660	2,883,040	2,947,390	1,822,820	1,702,470	1,747,750
Debt-to-assets ratio		0.35	0.35	0.40	0.40	0.40	0.49	0.49	0.37	0.36	0.35	0.41	0.40	0.39	0.33	0.25	0.24	0.23	0.37	0.26	0.25

March 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,133,660K ÷ $3,224,380K
= 0.35

The debt-to-assets ratio of Sarepta Therapeutics Inc has shown some fluctuations over the past quarters. The ratio was relatively stable around 0.35 to 0.40 from March 2021 to September 2023, indicating that the company had a moderate level of debt compared to its total assets during this period.

In the last quarter of 2023, the ratio increased to 0.49, suggesting a higher proportion of debt relative to assets. However, this was followed by a decrease to 0.37 in the first quarter of 2024, indicating a reduction in the company's debt burden in relation to its total assets.

Overall, the trend in Sarepta Therapeutics Inc's debt-to-assets ratio shows some variability but generally indicates that the company has maintained a prudent level of debt relative to its total assets. It is important for investors and stakeholders to monitor this ratio to assess the company's financial leverage and risk management.